Labiotech.eu

astrazeneca acerta pharma acquitision leukemia myeloma oncology cancer1

News and Trends 21 Dec 2015

Mystery Biotech No One has Ever Heard of in Biggest Deal of the Year for $7Bn

Acerta Pharma is an elusive Netherlands based Biotech with pipelines in Blood cancer and solid tumors which has somehow wrangled the biggest Biotech deal of 2015 with Pharma Giant AstraZeneca. Acerta Pharma is a Biotech start-up founded in 2012 which combines two technology platforms in drug discovery and development with a broad target range, from […]

December 21, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 21 Dec 2015

Here’s my Chat with the CBO of Immunocore, the Only EU Biotech to have ever raised €300M in one Round

Last Thursday at Genesis in London, I had the chance to meet with Eva-Lotta Allan, CBO of Immunocore (and previously from Ablynx). After a last-minute confirmation before the event, we came to meet and it helped me understand why Immunocore could be the next Biotech success-story in Europe… I’m sure you’ve heard of Immunocore this year. This […]

December 21, 2015 - 5 minutesmins - By Philip Hemme

News and Trends 19 Dec 2015

What happened this week? Top 10 Biotech gifts, Documentary on India, 10 Medtech Inventions

Monday: Discover India’s Growing Biotech ecosystem in our Latest Documentary! Tuesday: Becoming Cyborg: 10 Amazing MedTech Inventions in the Biotech Industry Wednesday: Top 10 Biotech Gifts You NEED to Consider this Christmas! Thursday: The Assault on Solid Tumors: How ‘Blinding’ Cancer is an Attractive Therapeutic Approach Friday: Finally! Galapagos New Mystery Partner to Replace AbbVie […]

December 19, 2015 - 1 minutemin - By Philip Hemme

ablynx antibodies rsv infection nanobody llama

News and Trends 18 Dec 2015

64 Million RSV Infections Per Year: Perhaps Alpaca Nanobodies Will Save Infant Lives

Ablynx, the Alpaca Nanobody Biotech from Belgium, has completed target enrollment of the first-in-infant Phase I/IIa study with its anti-Respiratory Syncytial virus, which is linked to 3,000-8,500 infant deaths each year. ALX-0171 is a wholly-owned Nanobody drug candidate administered through inhalation (nebulisation), for the treatment of respiratory syncytial virus (RSV) infection in infants. The candidate […]

December 18, 2015 - 3 minutesmins - By Dani Bancroft

Gilead galapagos abbvie filgotinib partner rheumatoid

News and Trends 18 Dec 2015

Finally! Galapagos New Mystery Partner to Replace AbbVie Revealed in €2Bn Deal

At last! We now know the fate of Galapagos Phase III Rheumatoid Arthritis drug after AbbVie‘s shocking abandonment. The Mystery replacement partner has now been revealed as Gilead! Galapagos will receive an upfront payment of €670M from California’s Gilead, consisting of a license fee of €277M and a €393M equity investment in Galapagos. In addition, […]

December 18, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 18 Dec 2015

Biotech of the week: Forendo Pharma, Finland hasn’t only got Santa Claus!

This week we leave Copenhagen but stay in Scandinavia, pass through Norway and arrive at this week’s destination, Finland. This country is famous being the home of Santa Claus (very fitting for this time of year), it’s large number of heavy metal bands and for inventing the sauna. It is also the residence of our […]

December 18, 2015 - 2 minutesmins - By Philip Hemme

hypoxia cancer hpv inthera aglaia oncology

News and Trends 17 Dec 2015

The Assault on Solid Tumors: How ‘Blinding’ Cancer is an Attractive Therapeutic Approach

The Dutch Oncology VC Specialist Aglaia has invested €3.4M in the Swiss Start-Up Inthera Bioscience for their Small molecule platform against solid tumors. Aglaia is a venture capital firm based in Bilthoven (NL) which has 3 funds under their management for specialist investment into Oncology research. Last year they raised over €50M as part of […]

December 17, 2015 - 3 minutesmins - By Dani Bancroft

ovarian cancer gamamabs antibodies bpifrance rothschild

News and Trends 16 Dec 2015

Ovarian Cancer Kills 50,000 Every Year. Now a French Biotech has Bagged €15M to Fight it.

GamaMabs from France (Paris & Toulouse) has secured a €15M Series B Fundraising round for its Antibody targeting Gynecological cancers. GamaMabs Pharma is a French biotechnology company developing innovative monoclonal antibodies in cancer. GamaMabs’ lead project is the monoclonal antibody (mAb) GM102 (formerly known as 3C23K), and they have previously partnered with Curie Cancer Institute […]

December 16, 2015 - 2 minutesmins - By Dani Bancroft

ngs bioinformatics biomerieux illumina microbiology immunoassay

News and Trends 16 Dec 2015

Global NGS Leader’s Influence in European Bioinformatics Field is Spreading Interest in Microbiomics

BioMérieux (France) is a diagnostics tech company which has partnered with the US Bioinformatics Giant Illumina to produce a novel Microbiological genetics sequencing kit: the bioMérieux EpiSeq. BioMérieux is a worldwide leading provider of diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and reduce risk of hospital […]

December 16, 2015 - 3 minutesmins - By Dani Bancroft

berlin myelo therapeutics chemo cancer drug trial

News and Trends 15 Dec 2015

Berlin Biotech Breakthrough: Myelo is Only 3 Years old and Already Starting a Phase II Trial for Breast Cancer!

Myelo Therapeutics in Berlin (Germany) has been approved for a phase II trial for its Chemo-induced Neutropenia therapy for Breast cancer after completing a successful series B financing round. A reduced level of neutrophils (a type of leukocyte) is called neutropenia. It can leave a patient vulnerable to infection and to developing febrile neutropenia, a […]

December 15, 2015 - 3 minutesmins - By Dani Bancroft

probiodrug small molecule alzheimers disease trial

News and Trends 15 Dec 2015

Latest Small Molecule against Alzheimer’s Disease Success in Phase I Trials

Probiodrug‘s phase I tolerability and efficacy trial for Alzheimer’s didn’t quite go as planned, although results are in and it is still good news for this small molecule candidate. Probiodrug in Halle (Germany) is pioneering immunotherapy approaches to eliminate pyroglutamated (pGlu) Abeta, a highly toxic peptide that has been linked to the progression of Alzheimer’s […]

December 15, 2015 - 3 minutesmins - By Dani Bancroft

Best in Biotech 15 Dec 2015

Becoming Cyborg: 10 Amazing MedTech Inventions in the Biotech Industry

There have been some truly amazing Med-tech developments this year, each sounding like they’re right out of Science fiction (Fringe, anyone?!). Here’s a few seriously worth talking about. Gradually, we too are becoming turning bionic in our attitude to medicine – and due to accessibility of manufacturing platforms, creative innovators like those in the Biohacking […]

December 15, 2015 - 8 minutesmins - By Dani Bancroft

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Mystery Biotech No One has Ever Heard of in Biggest Deal of the Year for $7Bn

Here’s my Chat with the CBO of Immunocore, the Only EU Biotech to have ever raised €300M in one Round

What happened this week? Top 10 Biotech gifts, Documentary on India, 10 Medtech Inventions

64 Million RSV Infections Per Year: Perhaps Alpaca Nanobodies Will Save Infant Lives

Finally! Galapagos New Mystery Partner to Replace AbbVie Revealed in €2Bn Deal

Biotech of the week: Forendo Pharma, Finland hasn’t only got Santa Claus!

The Assault on Solid Tumors: How ‘Blinding’ Cancer is an Attractive Therapeutic Approach

Ovarian Cancer Kills 50,000 Every Year. Now a French Biotech has Bagged €15M to Fight it.

Global NGS Leader’s Influence in European Bioinformatics Field is Spreading Interest in Microbiomics

Berlin Biotech Breakthrough: Myelo is Only 3 Years old and Already Starting a Phase II Trial for Breast Cancer!

Latest Small Molecule against Alzheimer’s Disease Success in Phase I Trials

Becoming Cyborg: 10 Amazing MedTech Inventions in the Biotech Industry

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!